Gentamicin perfusion vestibular response and hearing loss

Otology and Neurotology

Volumn 24, Issue 2, 2003, Pages 294-298

  Light, Joshua P ^a   Silverstein, Herbert ^a,b   Jackson, Lance E ^a  

^a Ear Research Foundation   (United States)

^b Florida Ear and Sinus Center   (United States)

Author keywords

Gentamicin; Hearing loss; M ni re's Disease; Vertigo; Vestibular function

Indexed keywords

GENTAMICIN;

ARTICLE; AUDIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; HEARING; HEARING LOSS; HUMAN; INNER EAR; MENIERE DISEASE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; RISK FACTOR; SPEECH DISCRIMINATION; VERTIGO; VESTIBULAR FUNCTION; VESTIBULAR SYSTEM; VESTIBULAR TEST;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUDIOMETRY, PURE-TONE; CALORIC TESTS; FEMALE; GENTAMICINS; HEARING LOSS, FUNCTIONAL; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPEECH DISCRIMINATION TESTS; SPEECH PERCEPTION; VESTIBULAR FUNCTION TESTS; VESTIBULE;

EID: 0037341174     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200303000-00027     Document Type: Article

References (18)

1. Blakley BW. Update on intratympanic gentamicin for Ménière's disease. Laryngoscope 2000;110:236-9.
2. Corsten M, Marsan J, Robichaud J. Treatment of intractable Ménière's disease with intratympanic gentamicin: review of the University of Ottawa experience. J Otolaryngol 1997;266:361-4.
3. Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion of gentamicin via a microcatheter in Ménière's disease. Otolaryngol Head Neck Surg 2001;124:203-7.
4. Youssef T, Poe D. Intratympanic gentamicin injection for the treatment of Ménière's disease. Am J Otol 1998;19:435-42.
5. Silverstein H, Rowan PT, Olds MJ, Rosenberg SI. Inner ear perfusion and the role of round window patency. Am J Otol 1997;18:586-9.
6. Silverstein H. Use of a new device, the MicroWick, to deliver medication to the inner ear. Ear Nose Throat J 1999;788:595-8, 600.
7. Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO. Direct round window membrane application of gentamicin in the treatment of Ménière's disease. Otolaryngol Head Neck Surg 1999;1205:649-55.
8. Hone SW, Nedzelski J, Chen J. Does intratympanic gentamicin treatment of Ménière's disease cause complete vestibular ablation? J Otolaryngol 2000;292:83-7.
9. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
10. Shelton C, Brackmann DE, House WF, Hitselberger WE. Acoustic tumor surgery: prognostic factors in hearing conversation. Arch Otolaryngol Head Neck Surg 1989;115:1213-6.
11. Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG. Intratympanic gentamicin instillation as treatment in Ménière's disease. Am J Otol 1993;14:278-82.
12. Driscoll CLW, Kasperbauer JL, Facer GW, Harner SG, Beatty CW. Low-dose intratympanic gentamicin and the treatment of Ménière's disease: preliminary results. Laryngoscope 1997;107:83-9.
13. Harner SG, Kasperbauer JL, Facer GW, Beatty CW. Transtympanic gentamicin for Ménière's syndrome. Laryngoscope 1998:1446-9.
14. Harner SG, Driscoll CLW, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome. Otol Neurotol 2001;22:210-5.
15. Hoffer ME, Kopke RD, Weisskopf P, et al. Use of the round window microcatheter in the treatment of Ménière's disease. Laryngoscope 2001;111(11 Pt 1):2046-9.
16. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Ménière's disease. Laryngoscope 2000;1108:1298-305.
17. Toth AA, Parnes LS. Intratympanic gentamicin therapy for Ménière's disease: preliminary comparison of two regimens. J Otolaryngol 1995;24:340-4.
18. Beck C, Schmidt CL. 10 years of experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Ménière. Arch Otolaryngol 1978;221:149-52.